查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1734911

2032 年药用管瓶和安瓿瓶市场预测：按产品、材料、产能、应用、最终用户和地区进行的全球分析

Pharmaceutical Glass Vials and Ampoules Market Forecasts to 2032 - Global Analysis By Product (Vials, Ampoules, Pre-filled Syringes and Dropper Bottles), Material, Capacity, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球药用管瓶和安瓿瓶市场预计在 2025 年达到 158 亿美元，预计到 2032 年将达到 286 亿美元，预测期内的复合年增长率为 8.9%。

药用玻璃西林管瓶和安瓿瓶是製药业用于储存和运输液体和粉末药物的专用容器。西林管瓶是圆柱形的小瓶子，底部平坦，配有橡胶塞或螺旋盖，常用于注射和疫苗。安瓿瓶是密封的玻璃容器，用于盛装单剂量无菌注射剂，必须打破才能取出内容物。两者均采用优质硼硅酸或钠钙玻璃製成，以确保化学稳定性、耐用性和抗热衝击性，从而保护药效并防止污染。

据印度药品製造商协会 (IDMA) 称，古吉拉突邦的药品产量约占印度全国的 33%。

对生物製药和注射疗法的需求不断增加

生物製药和注射疗法的需求日益增长，推动了药用管瓶和安瓿瓶市场的发展。随着先进生技药品和个人化医疗的日益普及，对无菌、安全且化学惰性的包装的需求也日益增长。管瓶和安瓿瓶具有优异的阻隔性，并且与敏感製剂相容，使其成为注射剂的理想选择。生物製药的发展以及肠外给药的激增，正在推动整个製药行业包装解决方案的持续成长和创新。

製造和营运成本高

高昂的製造和营运成本是药用管瓶和安瓿瓶市场面临的重大挑战。这些成本源自于昂贵的原料、先进的製造流程和严格的品管标准。因此，製造商面临着在确保产品安全性和可靠性的同时保持价格竞争力的压力。这些因素可能会影响盈利、限制创新，并导致产品价格上涨，最终影响最终用户的可及性，并降低市场成长潜力。

技术进步

技术进步正积极改变药用管瓶和安瓿瓶市场，提升产品品质、安全性和效率。精密成型、改良的灭菌技术和智慧包装等创新技术能够保护药品的完整性并延长保质期。自动化和数位化追踪简化了生产和供应链管理，降低了污染风险和人为错误。这些发展有助于满足法规合规性，并满足製药业对高纯度、无污染包装日益增长的需求，最终推动市场成长。

脆弱性和处理挑战

由于易碎性和搬运问题，药用管瓶和安瓿瓶市场面临巨大挑战。这些容器在使用、储存和运输过程中容易破损，导致成本增加、安全问题和产品损失。由于需要专业包装和搬运解决方案，物流复杂性也影响了供应链效率。因此，生产商正在投资购买更坚固的材料，但易碎性仍然是一个问题。

COVID-19的影响

新冠疫情对药用管瓶和安瓿瓶市场产生了重大影响。疫苗生产和分销的激增凸显了对可靠包装解决方案的需求。这导致对管瓶的需求增加，并促使製造商扩大生产规模。然而，原材料短缺、供应链中断以及严格的监管要求等挑战也带来了阻碍。儘管面临这些挑战，但市场仍在不断涌现创新和投资，推动着该产业的成长。

预计预测期内火石玻璃部分将成为最大的部分。

火石玻璃透明度高、经济高效且与各种製剂相容，预计在预测期内将占据最大的市场占有率。它能够清晰地显示内容物，确保更好的品管和患者安全，尤其适用于非光敏性注射药物。此外，它易于成型和加工，可实现扩充性生产，对于寻求高效可靠包装解决方案的製药商来说，它是一种极具吸引力的选择。

生技药品领域预计将在预测期内实现最高复合年增长率

预计生物製药领域将在预测期内实现最高成长率。这是因为生物製药高度敏感且需要复杂的储存条件。这些治疗方法需要无菌、无反应的容器来确保产品完整性，因此玻璃管瓶和安瓿瓶成为首选。生技药品投资的不断增长、单株抗体和基因疗法核准的不断增加，正在推动对优质药用玻璃包装的需求，从而刺激管瓶设计的技术创新，并扩大整个行业的生产能力。

占比最高的地区：

预计亚太地区将在预测期内占据最大的市场占有率，因为注射剂、疫苗和生物製药的需求不断增长，推动了人们采用能够确保安全性和延长保质期的优质包装解决方案。政府在医疗保健方面的支出不断增加，以及印度和中国等国製药製造业基地的不断扩张，进一步推动了这一成长。此外，玻璃技术的进步正在推动永续性和精准性，从而增强该地区的整体医疗保健生态系统。

复合年增长率最高的地区：

在预测期内，由于对安全可靠的医药包装解决方案的需求不断增长，预计北美将呈现最高的复合年增长率。该地区强大的医药製造基础加上严格的监管标准，确保了高品质的生产。技术进步以及生技药品和注射的兴起进一步推动了市场扩张。这种增长透过提高药物的稳定性和安全性，对公众健康产生了积极影响，同时支持了北美各地医药包装行业的技术创新和永续性发展。

免费客製化服务

订阅此报告的客户可享有以下免费自订选项之一：

  • 公司简介
    • 全面分析其他市场参与者（最多 3 家公司）
    • 主要企业的SWOT分析（最多3家公司）
  • 地理细分
    • 根据客户兴趣对主要国家市场进行估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 研究范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 限制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球药用管瓶和安瓿瓶市场（按产品）

  • 管瓶
  • 安瓿
  • 预填充式注射器
  • 滴管瓶

6. 全球药用管瓶和安瓿瓶市场（依材质）

  • 硼硼硅酸玻璃
  • 火石玻璃
  • 聚丙烯

7. 全球药用管瓶和安瓿瓶市场（按数量）

  • 小于2毫升
  • 2ml～5ml
  • 5ml～10ml
  • 10毫升或更多

8. 全球药用管瓶和安瓿瓶市场（按应用）

  • 疫苗
  • 注射
  • 生物製药
  • 化疗药物
  • 肿瘤药物
  • 其他用途

第九章全球药用管瓶和安瓿瓶市场（按最终用户）

  • 製药公司
  • 生物製药公司
  • 契约製造组织（CMO）
  • 研究和学术机构
  • 其他最终用户

第 10 章全球药用管瓶和安瓿瓶市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司概况

  • Gerresheimer AG
  • Schott AG
  • SGD Pharma
  • Stevanato Group
  • Nipro Corporation
  • Corning Incorporated
  • Shandong Pharmaceutical Glass Co., Ltd.
  • Piramal Glass
  • Borosil Limited
  • Ardagh Group
  • West Pharmaceutical Services, Inc.
  • Bormioli Pharma
  • Owens-Illinois, Inc.
  • AAPL Solutions Pvt. Ltd.
  • Hindusthan National Glass & Industries Ltd
  • Accu-Glass LLC
  • Stoelzle Glass Group
  • DWK Life Sciences GmbH
Product Code: SMRC29548

According to Stratistics MRC, the Global Pharmaceutical Glass Vials and Ampoules Market is accounted for $15.8 billion in 2025 and is expected to reach $28.6 billion by 2032 growing at a CAGR of 8.9% during the forecast period. Pharmaceutical glass vials and ampoules are specialized containers used to store and transport liquid and powdered medications in the pharmaceutical industry. Vials are small, cylindrical bottles with a flat bottom and a rubber stopper or screw cap, commonly used for injectable drugs and vaccines. Ampoules are sealed glass containers that hold a single dose of sterile injectable medicine and must be broken open to access the contents. Both are made from high-quality borosilicate or soda-lime glass to ensure chemical stability, durability, and resistance to thermal shock, protecting drug efficacy and preventing contamination.

According to the Indian Drug Manufacturers' Association (IDMA), Gujarat contributes to about 33% of the country's pharmaceutical production.

Market Dynamics:

Driver:

Rising Demand for Biopharmaceuticals and Injectable Therapies

The rising demand for biopharmaceuticals and injectable therapies is significantly boosting the pharmaceutical glass vials and ampoules market. As advanced biologics and personalized medicines gain traction, the need for sterile, secure, and chemically inert packaging grows. Glass vials and ampoules offer excellent barrier properties and compatibility with sensitive formulations, making them ideal for injectable drugs. This surge in biologic drug development and parenteral administration is driving consistent growth and innovation in packaging solutions across the pharmaceutical industry.

Restraint:

High Production and Operational Costs

High production and operational costs in the pharmaceutical glass vials and ampoules market pose significant challenges. These costs arise from expensive raw materials, advanced manufacturing processes, and stringent quality control standards. As a result, manufacturers face pressure to maintain competitive pricing while ensuring product safety and reliability. These factors hinder profitability, limit innovation, and may lead to higher product prices, ultimately affecting accessibility for end-users and reducing market growth potential.

Opportunity:

Technological Advancements

Technological advancements are positively transforming the pharmaceutical glass vials and ampoules market by enhancing product quality, safety, and efficiency. Innovations such as precision forming, improved sterilization techniques, and smart packaging enable better protection of drug integrity and longer shelf life. Automation and digital tracking streamline production and supply chain management, reducing contamination risks and human error. These developments support regulatory compliance and meet growing demand for high-purity, contamination-free packaging in the pharmaceutical industry, ultimately driving market growth.

Threat:

Fragility and Handling Challenges

The pharmaceutical glass vials and ampoules market is facing considerable hurdles due to fragility and handling issues. These containers are prone to breaking during usage, storage, and transit, which can lead to higher expenses, safety hazards, and product loss. Supply chain efficiency is impacted by the complexity of logistics brought on by the requirement for specialized packaging and handling solutions. Consequently, producers are spending money on stronger materials, yet fragility is still a problem.

Covid-19 Impact

The COVID-19 pandemic significantly impacted the pharmaceutical glass vials and ampoules market. The surge in vaccine production and distribution highlighted the critical need for reliable packaging solutions. This led to increased demand for glass vials, prompting manufacturers to scale up production. However, challenges such as raw material shortages, supply chain disruptions, and stringent regulatory requirements posed obstacles. Despite these challenges, the market has seen innovation and investment, driving growth in the sector.

The flint glass segment is expected to be the largest during the forecast period

The flint glass segment is expected to account for the largest market share during the forecast period, due to its excellent clarity, cost-effectiveness, and compatibility with a wide range of drug formulations. Its ability to provide clear visibility of contents ensures better quality control and patient safety, especially for non-sensitive injectable drugs. Moreover, its ease of molding and processing supports scalable production, making it an attractive choice for pharmaceutical manufacturers seeking efficient and reliable packaging solutions.

The biologics segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the biologics segment is predicted to witness the highest growth rate, due to the high sensitivity and complex storage needs of biologic drugs. These therapies require sterile, non-reactive containers to ensure product integrity, making glass vials and ampoules the preferred choice. Rising investments in biologics and increasing approvals of monoclonal antibodies and gene therapies are boosting demand for premium pharmaceutical glass packaging, fostering innovation in vial design and expanding production capacity across the industry.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share because of Rising demand for injectable drugs, vaccines, and biopharmaceuticals is driving adoption of high-quality packaging solutions, ensuring safety and extended shelf life. Governments' increased healthcare spending and the expansion of pharmaceutical production hubs in countries like India and China further fuel this growth. Additionally, advancements in glass technology promote sustainability and precision, enhancing the overall healthcare ecosystem in the region.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to rising demand for safe, reliable drug packaging solutions. The region's strong pharmaceutical manufacturing base, coupled with stringent regulatory standards, ensures high-quality production. Technological advancements and the rise in biologics and injectable drugs are further propelling market expansion. This growth positively impacts public health by enhancing drug stability and safety, while supporting innovation and sustainability efforts within the pharmaceutical packaging industry across North America.

Key players in the market

Some of the key players profiled in the Pharmaceutical Glass Vials and Ampoules Market include Gerresheimer AG, Schott AG, SGD Pharma, Stevanato Group, Nipro Corporation, Corning Incorporated, Shandong Pharmaceutical Glass Co., Ltd., Piramal Glass, Borosil Limited, Ardagh Group, West Pharmaceutical Services, Inc., Bormioli Pharma, Owens-Illinois, Inc., AAPL Solutions Pvt. Ltd., Hindusthan National Glass & Industries Ltd, Accu-Glass LLC, Stoelzle Glass Group and DWK Life Sciences GmbH.

Key Developments:

In May 2025, SCHOTT Pharma and Serum Institute of India (SII) have welcomed TPG Growth as a new strategic partner in their joint venture, SCHOTT Poonawalla. This collaboration marks a significant development in the pharmaceutical packaging sector in India.

In November 2023, SCHOTT and Accelink Technologies, a prominent provider of optical communication solutions, announced a long-term strategic partnership at the China International Import Expo (CIIE) in Shanghai. This collaboration aims to enhance the fiber optic communication supply chain and foster technological advancements in the field.

Products Covered:

  • Vials
  • Ampoules
  • Pre-filled Syringes
  • Dropper Bottles

Materials Covered:

  • Borosilicate Glass
  • Flint Glass
  • Polypropylene

Capacities Covered:

  • Less than 2ml
  • 2ml to 5ml
  • 5ml to 10ml
  • More than 10ml

Applications Covered:

  • Vaccines
  • Injectables
  • Biologics
  • Chemotherapy Drugs
  • Oncology Drugs
  • Other Applications

End Users Covered:

  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Contract Manufacturing Organizations (CMOs)
  • Research and Academic Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Pharmaceutical Glass Vials and Ampoules Market, By Product

  • 5.1 Introduction
  • 5.2 Vials
  • 5.3 Ampoules
  • 5.4 Pre-filled Syringes
  • 5.5 Dropper Bottles

6 Global Pharmaceutical Glass Vials and Ampoules Market, By Material

  • 6.1 Introduction
  • 6.2 Borosilicate Glass
  • 6.3 Flint Glass
  • 6.4 Polypropylene

7 Global Pharmaceutical Glass Vials and Ampoules Market, By Capacity

  • 7.1 Introduction
  • 7.2 Less than 2ml
  • 7.3 2ml to 5ml
  • 7.4 5ml to 10ml
  • 7.5 More than 10ml

8 Global Pharmaceutical Glass Vials and Ampoules Market, By Application

  • 8.1 Introduction
  • 8.2 Vaccines
  • 8.3 Injectables
  • 8.4 Biologics
  • 8.5 Chemotherapy Drugs
  • 8.6 Oncology Drugs
  • 8.7 Other Applications

9 Global Pharmaceutical Glass Vials and Ampoules Market, By End User

  • 9.1 Introduction
  • 9.2 Pharmaceutical Companies
  • 9.3 Biopharmaceutical Companies
  • 9.4 Contract Manufacturing Organizations (CMOs)
  • 9.5 Research and Academic Institutes
  • 9.6 Other End Users

10 Global Pharmaceutical Glass Vials and Ampoules Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Gerresheimer AG
  • 12.2 Schott AG
  • 12.3 SGD Pharma
  • 12.4 Stevanato Group
  • 12.5 Nipro Corporation
  • 12.6 Corning Incorporated
  • 12.7 Shandong Pharmaceutical Glass Co., Ltd.
  • 12.8 Piramal Glass
  • 12.9 Borosil Limited
  • 12.10 Ardagh Group
  • 12.11 West Pharmaceutical Services, Inc.
  • 12.12 Bormioli Pharma
  • 12.13 Owens-Illinois, Inc.
  • 12.14 AAPL Solutions Pvt. Ltd.
  • 12.15 Hindusthan National Glass & Industries Ltd
  • 12.16 Accu-Glass LLC
  • 12.17 Stoelzle Glass Group
  • 12.18 DWK Life Sciences GmbH

List of Tables

  • Table 1 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Vials (2024-2032) ($MN)
  • Table 4 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Ampoules (2024-2032) ($MN)
  • Table 5 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Pre-filled Syringes (2024-2032) ($MN)
  • Table 6 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Dropper Bottles (2024-2032) ($MN)
  • Table 7 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Material (2024-2032) ($MN)
  • Table 8 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Borosilicate Glass (2024-2032) ($MN)
  • Table 9 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Flint Glass (2024-2032) ($MN)
  • Table 10 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Polypropylene (2024-2032) ($MN)
  • Table 11 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Capacity (2024-2032) ($MN)
  • Table 12 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Less than 2ml (2024-2032) ($MN)
  • Table 13 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By 2ml to 5ml (2024-2032) ($MN)
  • Table 14 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By 5ml to 10ml (2024-2032) ($MN)
  • Table 15 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By More than 10ml (2024-2032) ($MN)
  • Table 16 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Application (2024-2032) ($MN)
  • Table 17 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Vaccines (2024-2032) ($MN)
  • Table 18 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Injectables (2024-2032) ($MN)
  • Table 19 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Biologics (2024-2032) ($MN)
  • Table 20 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Chemotherapy Drugs (2024-2032) ($MN)
  • Table 21 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Oncology Drugs (2024-2032) ($MN)
  • Table 22 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 23 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By End User (2024-2032) ($MN)
  • Table 24 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Pharmaceutical Companies (2024-2032) ($MN)
  • Table 25 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Biopharmaceutical Companies (2024-2032) ($MN)
  • Table 26 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Contract Manufacturing Organizations (CMOs) (2024-2032) ($MN)
  • Table 27 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Research and Academic Institutes (2024-2032) ($MN)
  • Table 28 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.